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Abstract. Continuous monitoring of blood oxygen saturation (SpO2) of the neonate
is essential to the quality of health care provided on a neonatal intensive care unit
(NICU). Current saturation sensors are usually placed at the hand or foot, which are
dependent of a peripheral blood supply. When the peripheral blood circulation of
neonates is compromised conventional peripheral pulse oximeters, in many cases, fail
to operate accurately or operate at all. A new reflectance anterior fontanelle (ANTF)
SpO2 sensor and instrumentation has been developed to investigate SpO2s from the
neonatal fontanelle. The underlying hypothesis is that perfusion at such a central
site such as the fontanelle should be preferentially preserved at time of compromised
peripheral circulation.
Fifteen neonates on an NICU (9 male, 6 female) with a median age of 7 days (IQR =
41.5 days) were selected for ANTF SpO2 monitoring. ANTF photoplethysmographic
(PPG) signals were monitored for a maximum period of two hours, during which
delivered oxygen concentration (FiO2) was artificially altered in order to study the
sensitivity of the new custom made sensor compared to a commercial pulse oximeter.
The developed system and custom made sensors were successful at acquiring good
quality signals at both wavelengths necessary for pulse oximetry calculations. SpO2
changes at times of FiO2 change are observable in all three SpO2 sensors used,
confirming the sensitivity of the ANTF sensor. ANTF SpO2s, estimated from the
acquired PPGs, were in broad agreement with SpO2s obtained from the commercial
foot pulse oximeter. A Bland and Altman analysis of the differences between SpO2s
from the fontanelle PPG sensor and the commercial device show a relatively small mean
difference (d = ±2.2%), but with a wide variation (2s = ±17.4%) this observation,
however may be due to the varied levels of ill health patients and is backed up by
comparing the commercial device SpO2 readings at the same moment a blood gas
sample was taken (d = −4.8%, 2s = ±15.8%).
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1. Introduction
The pulse oximeter relies on the presence of peripheral arterial pulsations, also known
as the photoplethysmograph (PPG), which is detected by an optoelectronic sensor
comprising an infra red and red light source and a photo-detector. Instrumentation
is used to convert the current from the photodiode into voltage signals which are then
digitised and used to estimate SpO2 (Kyriacou et al. n.d.).
It has been shown that various physiological and pathological conditions can cause
commercial pulse oximetry sensors to fail in estimating accurately or estimate at all SpO2
values (Lawson et al. 1987, Morris et al. 1989, Severinghaus & Spellman 1990, Trivedi
et al. 1997). In these reviews the ability of the devices under investigation to detect an
arterial pulse varied, and even went as far as to point out that some oximeters were in
fact very good at detecting pulses of small amplitude (Lawson et al. 1987) when the
arm was occluded up to 93% of systolic pressure. Most, if not all, of the studies were
performed on adults receiving hospital care or on volunteers.
There is, however, limited knowledge on the performance of pulse oximeters in
paediatric or neonatal populations. There have been some studies (Iyer et al. 1996,
Levene & McKenzie 1988, Moller et al. 1993, Morgan & Durbin 1986, Reich et al. 1996)
where the investigators explored the accuracy of pulse oximeters in paediatric or neonatal
populations. The vast majority of PPG/SpO2 sensors used in these studies were
placed on the finger, ear or foot. In conclusion these studies showed that when the
patient’s peripheral perfusion was poor due to various physiological and/or pathological
conditions the accuracy and reliability of the pulse oximeters was compromised. It is
ironic that it is at these times that a reliable and almost instantaneous estimation of
SpO2 would be of most benefit to health-care professionals and patients.
Specifically, Villanueva et al (Villanueva et al. 1999) set out to assess a selection
of pulse oximetry failure criteria in 19 children of 10 years of age or less including
blood flow and pulse pressure. The main results concluded that low blood flow, induced
artificially by increasing cuff pressure has little effect on the ability of the pulse oximeter
to perform its functions, as arterial pulsations at the periphery were still detectable
at high occluding pressures. The end of this study noted that it took at least two
factors to affect the pulse oximeter significantly, particularly the combination of low
skin temperature and low haemoglobin concentration, thus giving support that systemic
vasoconstriction, induced by cold periods or hypovolaemia does significantly affect pulse
oximeter function.
There is the suggestion (Sedaghat-Yazdi et al. 2008) that some transmission pulse
oximetry sensors are less accurate when placed on the sole or palm, as opposed to the
finger or toe when SpO2 is less than 90%. In neonatal and paediatric populations the
small dimensions of the infant toe or finger make them inadequate for proper attachment
and so accuracy and precision may be also affected when the sensors designed for specific
areas of anatomy are alternatively placed.
A number of researchers and manufacturers tried to overcome these problems
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by designing various reflectance mode sensors for use in locations where it has
been suggested that perfusion is preserved at times when the periphery has failed.
These include oesophageal sensors (Kyriacou 2006, Kyriacou et al. 2008, Grubb
et al. 2014), and head/scalp/trunk sensors (Faisst et al. 1995, Dassel et al. 1997, Faisst
et al. 1997, Berkenbosch & Tobias 2006).
Excellent progress has been made in utilising reflectance PPG technology in
neonates as a heart rate monitor (Grubb et al. 2014), and the forehead is acknowledged
to better maintain perfusion compared to the extremities. As the vasculature in the
forehead is shared almost globally over the entire head it is our belief that other
locations could be utilised for PPG monitoring. Grubb et al (Grubb et al. 2014) used
a one wavelength, green light (525 nm), in their study rather than the traditional two
wavelengths of red and infrared light (660 and 940 nm respectively) used for SpO2
monitoring, citing that this wavelength has better amplitude characteristics that make
it ideal for pulsatile/heart rate analysis.
A pilot study on ten adult volunteers (Mendelson et al. 2006) demonstrated that it
was possible to acquire SpO2 readings from the forehead using a reflectance sensor. The
sensor was set-up against a conventional finger sensor, where only a small difference in
the mean and standard deviation of the values between sites was observed. Other studies
into pulse oximetry from the head, whether from paediatrics or adults, showed that they
were prone to giving falsely high or low readings when compared against readings from
a peripheral location. Six adults and seven neonates were selected for a study (Nijland
et al. 1995) to compare the effect of pulsating arteries on reflectance pulse oximetry. To
make the comparison the sensor was placed either on the forehead or the temple, where
the effect of the superficial temporal artery on pulse oximetry could be studied closely
and without any invasive intervention. The orientation of the sensor on the temple was
varied between having either the LEDs or the photodiode directly over the blood vessel.
When the photodiode was placed over the artery SpO2s were shown to be lower in both
populations (7.5% and 5.8% for neonates and adults respectively) than the reading from
the forehead. When the sensor was reorientated, so that the LEDs were over the artery,
there was an insignificant change in SpO2, however the plethysmograph signals were
larger than those acquired at the forehead.
It is either the forehead or the temple that seem to be the main focus for reflectance
pulse oximetry on the head; this is probably suggestive of the fact that these two
locations are generally easy to locate a sensor since there is no obstruction that may
be caused by hair. In neonates, who are often born with little or no hair, there exists
the opportunity to position the sensor in other scalp locations where SpO2 monitoring
may be unaffected by the phenomena previously described. Two studies of reflectance
pulse oximetry in neonates describe at least one other location (Faisst et al. 1995, Dassel
et al. 1997).
The first study (Faisst et al. 1995) recruited thirty-one neonates from an ICU who
had a reflectance sensor placed on the forehead, cheek, occiput (back of the head)
and back, in turn, to determine optimal positioning of the sensor. The second study
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(Dassel et al. 1997) solely concentrated on placing the sensor on the scalp (eight separate
locations) of only seven healthy infants. In the first study (Faisst et al. 1995) the
authors reported close agreements between SpO2 and heart rate for the reflectance
sensor versus a transmission sensor placed simultaneously on the hand. It was noted
that the reflectance sensor placed on the lower back was unreliable and susceptible to
breathing artefacts. From the plethysmograph signals recorded in the second study
(Dassel et al. 1997) it was observed that there was a clear difference in the effect of
location, with up to a 13% difference in SpO2s. Dassel (Dassel et al. 1997) states that
the differences observed can be explained by the optical differences of varying tissues
at each of the locations. Interestingly it is when there is a space in the skull (over
the fontanelle) where the largest red/infra red values are observed, which again can be
attributed by specific optical properties of the underlying tissues, and in this case the
specific lack of skull.
The chance to study PPGs from the fontanelle and underlying soft tissue was the
primary motivation to design and fabricate a reflectance-based sensor that can be located
on the anterior fontanelle (ANTF) (May et al. 2011).
The fontanelle are the soft areas of unformed skull on a new born that aid in
the birthing procedure, distorting the shape of the head temporarily for easier passage
through the birth canal. They also aid in the rapid growth of the head during infancy,
and dont fully solidify until about 24 months old (Graaff et al. 2009).
The motivation of this study is to investigate for the first time PPGs and SpO2s
acquired from the ANTF and to compare them with PPGs and SpO2S acquired from
a peripheral site such as the foot. The hypothesis underlying this study is that the
perfusion of the brain will be preferentially preserved at times where the periphery
is compromised and hence peripheral pulse oximeters might fail to estimate accurately
blood oxygen saturation, while the ANTF pulse oximeter will provide reliable monitoring
of SpO2.
2. Materials and Methods
2.1. Instrumentation
Optically and electrically identical reflectance ANTF and foot PPG sensors and
instrumentation have been designed and developed. The technical details of these
developments have been reported in the literature (May et al. 2011).
In brief an ANTF and foot reflectance PPG sensors were constructed using a flexible
PCB substrate (Pyralux, DuPont, USA). The red (660 nm) and infrared (940 nm) LEDs
were of identical dimensions (2 1.25 1.1 mm, LxWxH) (KP-2012 series, Kingbright,
Taiwan) and were arranged in a dual-light source configuration 5 mm either side of
the photo-diode (5 4.25 1.12 mm, LxWxH, active area = 7.5 mm2) (TEMD5010X01,
Vishay, USA) figure 1.
The ANTF sensor was enclosed within a medical-grade clear epoxy resin, to isolate
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Figure 1. Top-down oblique view of neonatal skull and anterior fontanelle, with the
concept of sensor component layout overlaid.
it electrically, and placed within a de-constructed ECG patch. It was terminated with
a flat ribbon cable and connector.
A PPG processing system was also designed and fabricated to; drive and multiplex
the LEDs (red and near infra red); convert the returning photo-diode current to a
voltage signal; de-multiplex the voltage PPG signal into separate signals for the red and
infra red LEDs; and filter any unwanted noise. A data-acquisition card (DAQ) (16-bit,
USB-6212, National Instruments, USA) was used to digitise (Fs = 200 Hz) the raw
PPG signals. The electronics and DAQ were enclosed, with dedicated DC power supply
(two parallel 12 V, 2 Ah batteries), into an electronically shielded instrumentation case
with external connectors for the separate PPG sensors, USB data cable and controls for
adjusting the LED drive current and gain of the transimpedance amplifier.
A custom LabVIEW (National Instruments, USA) data-acquisition virtual
instrument (VI) was developed for interfacing with the DAQ card, and for displaying
the PPG signals in real time and performed online heart rate and SpO2 estimation. The
VI stored the unprocessed signals for further off-line analysis.
2.2. Clinical Measurements
Following research ethics approval and parental consent, measurements were carried
out on 15, ASA I, II and III (American Society of Anaesthesiologists physical status
classification system) neonates (9 male, 6 female) with a median gestational age of 7 days
(inter-quartile range = 41.5 days) and a median weight of 3.2 kg (SD = 0.8 kg). The
study took place in the neonatal intensive care unit of Great Ormond Street Hospital
for Children, London, UK.
Candidates were selected on ward rounds by the lead clinician against the list
of inclusion/exclusion criteria specified in the approved protocol. Candidates were
excluded from the study if they were born at less than 36 weeks gestation, had abnormal
fontanelle anatomy, were not sedated and not receiving any complimentary respiratory
or oxygen support.
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Five ASA I patients (not on mechanical respiratory support, but receiving
complimentary oxygen therapy) seven ASA II patients (on conventional ventilator
respiratory support), and 3 ASA III patients (on oscillator breathing support) were
recruited for this study. Prior to the study the ANTF and foot sensors were cleaned with
alcohol wipes and placed into clear adhesive sterile pockets (TegadermTM, 3M, USA).
The custom made foot PPG sensor was secured on the sole of the foot with standard
medical tape. A commercial transmission SpO2 sensor (Phillips Medical, USA) was
placed on the other foot of the neonate as part of the standard hospital protocol. This
commercial pulse oximetry sensor enabled comparative SpO2 studies with the custom
made ANTF sensor.
The lead clinician manoeuvred the ANTF sensor over the fontanelle until PPGs
with good quality were observed. The ANTF sensor was then secured into position
with a bandage that was wrapped around the back of the head. Figure 2 shows the
experimental set up of the ANTF PPG monitoring with the foot PPGs as a reference.
At the time of the next routine blood sample for blood gas analysis, the study was
commenced and time stamped in the data file with a time-stamp function built into the
VI. The results from this blood gas analysis were used as the gold-standard, enabling
the comparison between the custom made sensors and that of the commercial SpO2
device.
Monitoring continued for a maximum of thirty minutes in order to establish
a baseline PPG reading, after which the fractional inspired oxygen (FiO2) being
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Figure 2. Experimental setup for anterior fontanelle monitoring. The neonate (A)
has PPGs simultaneously recorded from the anterior fontanelle (B), using the custom
made ANTF sensor (C), and the foot (D). The commercial SpO2 sensor (E) is left
in situ for comparative analysis. The custom sensors are connected to the custom
instrumentation (F), which is connected via a USB cable (G) to a laptop with custom
recording software (H).
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administered to the patient as part of the routine care was increased by 50% of the
baseline setting and continued for a maximum of one hour, after which FiO2 was
decreased back to the baseline setting. This was done to see if the custom sensor
was sensitive to oxygen concentration change. During the study SpO2 values, heart and
respiration rates acquired by commercial medical devices were manually recorded. All
blood gas tests carried out during this time were also marked into the raw data file using
the time stamp function on the VI.
2.3. Data Analysis
Prior to SpO2 estimation,the raw PPG signals were inspected analysed with a fast
Fourier transform function (FFT), implemented in MATLAB (MathWorks, USA) to
determine the most suitable parameters for filtering and signal normalisation. All the
PPG signals were normalised using the formula in (1).
PPGN =
PPGAC
PPGDC
(1)
where PPGAC was the AC portion of the signal and PPGDC was the DC portion (?).
The normalised signals were filtered using band pass filters implemented in
MATLAB (MathWorks, USA). The band-stop and band-pass values were set to
incorporate the fundamental frequency due to heart rate for each patient individually,
thus eliminating any respiratory (natural or mechanical) artefact.
Time stamps recorded by the user on the VI during the clinical trials, indicating
when a blood gas measurement was made, were used to isolate the section of PPG signals
at those times. No calibration was made to derive an SpO2 curve for the custom sensors
and system, as the protocol was designed to look for changes in concentration, regardless
of the actual SpO2 value. Instead SpO2 was estimated using the linear formulae (2) and
(3).
SpO2 = 110− 25R (2)
R =
PPGNred
PPGNir
(3)
described in (Webster 1997) where PPGNred and PPGNir were the normalised
amplitudes of the red and infrared PPG signals respectively.
The limits of agreement between the ANTF SpO2 results and those from the
commercial toe pulse oximeter and the blood gas analyser were calculated using
the between-method differences analysis outlined by Bland and Altman (Bland &
Altman 1986).
3. Results
Photoplethysmographs at both wavelengths (red and infrared) were acquired successfully
from the fontanelle and the foot of all neonates. Figure 3 shows typical fontanelle and
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foot PPGs respectively for the infrared and red wavelengths with respiration modulation.
A comparison of the SpO2 values obtained from the ANTF vs the commercial device
and the gold standard can be seen in the boxplot in figure 4.
A total of 26 pairs of SpO2 values from the 16 patients were used to compare
the ANTF and the commercial foot pulse oximeter. Figure 5 is a plot of the
difference between the ANTF and the commercial foot SpO2 values against their mean.
Calculations of the bias, estimated by the mean difference and the standard deviation
of the differences were performed to assess the degree of agreement between the two
methods. The bias (d) is the ANTF pulse oximeter reading minus the commercial foot
pulse oximeter reading and was 2.2% with a standard deviation (s) of ±8.7%. Hence,
the limits of agreement for the SpO2 data (ANTF and commercial foot) were:
d− 2s = +2.2− (2× 8.7) = −15.2% (4)
d− 2s = +2.2 + (2× 8.7) = +19.6% (5)
The results from the Bland and Altman analysis of the commercial and fontanelle
pulse oximeters showed wide limits of agreement which is uncharacteristic of most pulse
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Figure 3. A ten-second sample of PPGs acquired simultaneously from the anterior
fontanelle and foot. The infrared and red PPG signals from the ANTF are shown by
(A) and (B) respectively, whilst the infrared and red signals acquired from the foot are
shown in plots (C) and (D) respectively. Clearly visible are the pulsations due to the
heart, and the modulation from breathing. HR ≈ 141 bpm, RR ≈ 35.
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Figure 4. Boxplot of SpO2(ANTF, foot and commercial device) and Blood Gas
(SaO2) results, n = 26.
oximeters operating within normal conditions.
One of the factors that might have caused such large deviation from the mean is
the fact the the custom ANTF pulse oximeter is not calibrated.
In order to investigate this further and establish the source of such deviation another
Bland and Altman analysis was performed comparing the gold standard blood gas
analysis (BGA) with the commercial foot pulse oximeter. For this analysis a total
of 26 pairs of SpO2 values from the 16 patients were used to compare the commercial
foot pulse oximeter with the BGA. Figure 6 is a plot of the difference between the BGA
and the commercial foot SpO2 values against their mean.
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Figure 5. Bland and Altman plot of all SpO2 results (Commercial vs ANTF) from
all 15 patients, n = 621.
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Figure 6. Bland and Altman plot of the saturation results (gold standard SaO2 vs.
commercial) from all 15 patients, n = 26.
The same calculations as described for the ANTF vs the commercial foot SpO2
were carried out for the BGA verses the foot SpO2, where a bias (d) of −4.85% and
standard deviation (s) of ±7.9% were computed. The limits of agreement for the BGA
against Foot SpO2 were therefore:
d− 2s = −4.85− (2× 7.9) = −20.65% (6)
d− 2s = −4.85 + (2× 7.9) = +10.95% (7)
4. Discussion
This pilot study has shown successfully that PPGs of good quality at both red and
infrared wavelengths can be acquired from the neonatal anterior fontanelle.
In figure 4 the boxplot shows the results of SpO2 estimation at the same moments
blood gas samples were taken. In general it can be said that the commercial device and
the fontanelle sensor both slightly over-estimate oxygen saturation, but the fontanelle
sensor has similar variation to the blood gas results. The wider variation in SpO2
values compared to the custom foot sensor may be due to the unique anatomy of
the fontanelle or localised saturation variations, but this remains a conjecture and
needs more rigorous investigation and comparison against another method, such as
near infrared spectroscopy (NIRS).
These differences compared to the commercial device may also be due to
proprietary on-board processing algorithms that eliminate erroneous SpO2 values based
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on automatic real-time signal analysis, whereas the gold-standard and custom sensors,
calculate an instantaneous reading based on the sample taken at that moment using
well established numerical methods.
An overall look at the SpO2 estimation from the fontanelle compared to the
commercial device (Phillips Medical pulse oximeter, USA) in the first Bland-Altman
analysis, figure 5, reveals only a small difference in SpO2 estimation (+2.2%), however
the large limits of agreement seen in this result (2s = ±17.4%) are likely due to the
wide variety of observed gold-standard blood gas results (due to varying health of ICU
patients), and is backed up by the second Bland-Altman analysis, figure 6, comparing
the gold standard with the commercial device (d = −4.85%, 2s = ±15.8%).
5. Conclusion
The large limits of agreement for the two commercial methods of oxygen saturation
measurement (Foot SpO2 and BGA) would appear to back up the large limits of
agreement seen between the fontanelle sensor and the commercial pulse oximeter for
this group of patients. A controlled experiment with healthy subjects with similar
health may prove useful to help back up this observation further.
From this study it is reasonable to conclude that the fontanelle sensor is at least
as accurate as the commercial sensor, even when no specific calibration curve has been
determined for this unique anatomical geometry.
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